新生内膜
再狭窄
血小板源性生长因子受体
内膜增生
增殖细胞核抗原
血管平滑肌
血小板衍生生长因子
原位杂交
信使核糖核酸
干扰素γ
医学
病理
生物
生长因子
免疫学
内科学
细胞因子
免疫组织化学
平滑肌
支架
受体
基因
生物化学
作者
Ji J,Lu Si,Wen‐Liang Fang,William Ling
出处
期刊:PubMed
日期:2001-02-01
卷期号:114 (2): 139-42
被引量:2
摘要
To elucidate the mechanism of interferon-gamma (IFN-gamma) to inhibit the restenosis after successful percutaneous transluminal angioplasty (PTA).A rabbit vascular restenotic model was constructed and the proliferation of intimal smooth muscle cells (SMCs) were observed by monitoring their expression of proliferating cell nuclear antigen (PCNA) and platelet-derived growth factor beta chain mRNA (PDGF-beta mRNA) at the indicated time points.IFN-gamma could significantly inhibit the expression of PCNA by intimal SMCs one week after denudation, when counting 200 intimal cells for PCNA-positive reactions with an inhibitory rate of 88.50% (P < 0.001). IFN-gamma could downregulate in situ expression of PDGF-beta mRNA by these cells as we calculated the average number of PDGF-beta mRNA positive cells per square millimetre area at x 400 magnification with reduced rates of 86.85% in 1 week group (P < 0.001), of 93.66% in 2 week group (P < 0.001) and of 52.92% in 4 week group (0.02 < P < 0.05), respectively.The local production of PDGF-beta by vascular intimal SMCs via an autocrine mechanism may be responsible for continuous proliferation of these cells and the formation of neointima after injury. This could be inhibited by IFN-gamma through downregulating the expression of PDGF-beta mRNA. These results provide an in vivo basis for IFN-gamma to be used clinically for the management of restenosis after percutaneous transluminal angioplasty.
科研通智能强力驱动
Strongly Powered by AbleSci AI